Healthcare entity
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Astellas Pharma, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: medical-devices. Of the tracked stories, 1 of 1 also mention Astellas Pharma, the most common co-covered peer. Each story carries 2 original sources on average, compared with 2.8 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.8. We currently track 1 Healthcare story that mention Michel Maharbiz, all published on March 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Michel Maharbiz. Shared-story counts are live from our verified record — not editorial picks.
The founder of Iota Biosciences has been named the keynote speaker for the 2026 Bioelectronic Medicine Forum in New York City. This announcement highlights the growing prominence of 'neural dust' technology and its potential to revolutionize chronic disease management through ultra-miniature bioelectronic implants.
Source: itnewsonline.com · winknews.com
Michel Maharbiz is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
